NZ602249A - Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders - Google Patents
Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disordersInfo
- Publication number
- NZ602249A NZ602249A NZ602249A NZ60224911A NZ602249A NZ 602249 A NZ602249 A NZ 602249A NZ 602249 A NZ602249 A NZ 602249A NZ 60224911 A NZ60224911 A NZ 60224911A NZ 602249 A NZ602249 A NZ 602249A
- Authority
- NZ
- New Zealand
- Prior art keywords
- treatment
- glucomannan
- alginate
- xanthan gum
- food
- Prior art date
Links
- 208000030159 metabolic disease Diseases 0.000 title abstract 5
- 235000013305 food Nutrition 0.000 title abstract 3
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 title abstract 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 title abstract 2
- 229920002581 Glucomannan Polymers 0.000 title abstract 2
- 229940072056 alginate Drugs 0.000 title abstract 2
- 235000010443 alginic acid Nutrition 0.000 title abstract 2
- 229920000615 alginic acid Polymers 0.000 title abstract 2
- 229940046240 glucomannan Drugs 0.000 title abstract 2
- 229920001285 xanthan gum Polymers 0.000 title abstract 2
- 235000010493 xanthan gum Nutrition 0.000 title abstract 2
- 229940082509 xanthan gum Drugs 0.000 title abstract 2
- 239000000230 xanthan gum Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 4
- 208000016097 disease of metabolism Diseases 0.000 abstract 2
- 239000000835 fiber Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000013325 dietary fiber Nutrition 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000003050 macronutrient Effects 0.000 abstract 1
- 235000021073 macronutrients Nutrition 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/27—Xanthan not combined with other microbial gums
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/723—Xanthans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31263010P | 2010-03-10 | 2010-03-10 | |
| US35765810P | 2010-06-23 | 2010-06-23 | |
| PCT/CA2011/000260 WO2011109900A1 (en) | 2010-03-10 | 2011-03-10 | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ602249A true NZ602249A (en) | 2014-10-31 |
Family
ID=44560211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ602249A NZ602249A (en) | 2010-03-10 | 2011-03-10 | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110223192A1 (enExample) |
| EP (1) | EP2544696B1 (enExample) |
| JP (3) | JP2013525269A (enExample) |
| KR (1) | KR20130039726A (enExample) |
| CN (1) | CN102892421A (enExample) |
| AU (2) | AU2011226708B2 (enExample) |
| BR (1) | BR112012022799B1 (enExample) |
| CA (2) | CA2791418C (enExample) |
| NZ (1) | NZ602249A (enExample) |
| RU (1) | RU2553348C2 (enExample) |
| SG (1) | SG183543A1 (enExample) |
| WO (1) | WO2011109900A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010039734A1 (de) * | 2010-08-25 | 2012-03-01 | Bayer Materialscience Aktiengesellschaft | Katalysator und Verfahren zur Herstellung von Chlor durch Gasphasenoxidation |
| GB201110672D0 (en) * | 2011-06-23 | 2011-08-10 | M I Drilling Fluids Uk Ltd | Wellbore fluid |
| TWI469785B (zh) * | 2012-04-25 | 2015-01-21 | Inovobiologic Inc | 用於治療代謝性疾病之膳食纖維組成物 |
| RU2672594C2 (ru) * | 2013-07-01 | 2018-11-16 | Юниверсити Оф Саутерн Калифорния | Состояние воздержания от пищи в качестве диетического лечения диабета |
| CN104277130A (zh) * | 2013-07-02 | 2015-01-14 | 中国科学院上海药物研究所 | 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途 |
| CN103604884B (zh) * | 2013-11-21 | 2015-10-28 | 南京工业大学 | 一种检测海藻生物质内还原性糖类物质的方法 |
| EP3082466B1 (en) * | 2013-12-18 | 2019-08-21 | Thylabisco AB | Use of thylakoids to reduce the urge for palatable food |
| KR20160001935A (ko) | 2014-06-30 | 2016-01-07 | 원광대학교산학협력단 | 블랙 커런트 추출물을 유효성분으로 함유하는 대사증후군의 예방, 개선 또는 치료를 위한 조성물 |
| CN104391049B (zh) * | 2014-09-20 | 2017-03-22 | 鄂尔多斯市中轩生化股份有限公司 | 黄原胶微量溶剂残留量的检测方法 |
| SMT202300091T1 (it) * | 2014-11-26 | 2023-05-12 | Omega Pharma Innovation And Dev Nv | Composizione di fibre dietetica |
| ES2857557T3 (es) * | 2015-01-26 | 2021-09-29 | Kaleido Biosciences Inc | Compuestos terapéuticos de glicano y métodos relacionados de los mismos |
| CA3224535A1 (en) * | 2016-01-12 | 2017-07-20 | University Of Southern California | Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers |
| US10485253B2 (en) | 2017-08-21 | 2019-11-26 | Mustapha Benmoussa | Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber |
| EP3827027A4 (en) | 2018-07-23 | 2022-04-27 | Nutragenom, LLC | COMPOSITION AND METHODS FOR GENERATE AND MAINTAIN MOLECULAR HYDROGEN (H2) IN AQUEOUS SYSTEMS |
| CN110412157A (zh) * | 2019-07-17 | 2019-11-05 | 广州金评检测研究院有限公司 | 一种烟酰胺原料中烟酸的测定方法 |
| JP7412759B2 (ja) * | 2020-04-16 | 2024-01-15 | 松谷化学工業株式会社 | 水溶性食物繊維のエネルギー量の簡便な測定方法 |
| CN112933105A (zh) * | 2021-02-10 | 2021-06-11 | 浙江工业大学 | 甘露葡萄糖醛酸多（寡）糖及硫酸化衍生物在制备治疗非酒精性脂肪肝药物中的应用 |
| CN112782321A (zh) * | 2021-03-09 | 2021-05-11 | 上海市质量监督检验技术研究院 | 一种快速检测纺织品中维生素e含量的测定方法 |
| CN117665192A (zh) * | 2023-06-30 | 2024-03-08 | 辰欣药业股份有限公司 | 一种特殊医学用途全营养配方乳剂食品中钾、钙、钠、镁的测定方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0683118B2 (ja) * | 1988-01-19 | 1994-10-19 | 日本電気株式会社 | 直流終端回路 |
| JPH02245148A (ja) * | 1989-03-17 | 1990-09-28 | Unie Koroido Kk | グルコマンナンの凝固方法及びこれに用いる組成物 |
| US5460957A (en) * | 1992-04-28 | 1995-10-24 | Maruha Corporation | Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate |
| US20020044988A1 (en) * | 2000-08-22 | 2002-04-18 | Fuchs Eileen C. | Nutritional composition and method for improving protein deposition |
| GB0406013D0 (en) * | 2004-03-17 | 2004-04-21 | Chiron Srl | Analysis of saccharide vaccines without interference |
| US8062686B2 (en) * | 2005-04-12 | 2011-11-22 | InovoBiologics, Inc. | Dietary supplement, and methods of use |
| US8597709B2 (en) * | 2005-04-12 | 2013-12-03 | Inovobiologic Inc. | Dietary supplement and methods of use |
-
2011
- 2011-03-10 RU RU2012142237/15A patent/RU2553348C2/ru not_active IP Right Cessation
- 2011-03-10 CA CA2791418A patent/CA2791418C/en active Active
- 2011-03-10 EP EP11752778.8A patent/EP2544696B1/en active Active
- 2011-03-10 SG SG2012064176A patent/SG183543A1/en unknown
- 2011-03-10 CN CN2011800216956A patent/CN102892421A/zh active Pending
- 2011-03-10 AU AU2011226708A patent/AU2011226708B2/en active Active
- 2011-03-10 CA CA2859055A patent/CA2859055A1/en not_active Abandoned
- 2011-03-10 US US13/045,285 patent/US20110223192A1/en not_active Abandoned
- 2011-03-10 KR KR1020127026489A patent/KR20130039726A/ko not_active Ceased
- 2011-03-10 NZ NZ602249A patent/NZ602249A/en unknown
- 2011-03-10 WO PCT/CA2011/000260 patent/WO2011109900A1/en not_active Ceased
- 2011-03-10 BR BR112012022799-8A patent/BR112012022799B1/pt not_active IP Right Cessation
- 2011-03-10 JP JP2012556355A patent/JP2013525269A/ja active Pending
-
2014
- 2014-08-14 AU AU2014213536A patent/AU2014213536A1/en not_active Abandoned
-
2015
- 2015-01-22 JP JP2015010059A patent/JP2015083604A/ja active Pending
-
2017
- 2017-01-04 JP JP2017000123A patent/JP2017074072A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012022799A2 (pt) | 2021-03-23 |
| AU2014213536A1 (en) | 2014-09-04 |
| US20110223192A1 (en) | 2011-09-15 |
| KR20130039726A (ko) | 2013-04-22 |
| JP2013525269A (ja) | 2013-06-20 |
| JP2017074072A (ja) | 2017-04-20 |
| AU2011226708B2 (en) | 2015-04-02 |
| CA2791418A1 (en) | 2011-09-15 |
| JP2015083604A (ja) | 2015-04-30 |
| CA2791418C (en) | 2016-07-05 |
| AU2011226708A1 (en) | 2012-09-27 |
| EP2544696B1 (en) | 2019-05-22 |
| CN102892421A (zh) | 2013-01-23 |
| WO2011109900A1 (en) | 2011-09-15 |
| SG183543A1 (en) | 2012-10-30 |
| RU2012142237A (ru) | 2014-04-20 |
| BR112012022799B1 (pt) | 2021-11-30 |
| RU2553348C2 (ru) | 2015-06-10 |
| EP2544696A1 (en) | 2013-01-16 |
| EP2544696A4 (en) | 2013-08-21 |
| CA2859055A1 (en) | 2011-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ602249A (en) | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders | |
| Lordan et al. | Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components | |
| Rastall et al. | Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health | |
| Mendis et al. | Present and future prospects of seaweeds in developing functional foods | |
| MY187609A (en) | Human milk oligosaccharides to ameliorate symptoms of stress | |
| IN2012DN03632A (enExample) | ||
| Versalovic | The human microbiome and probiotics: implications for pediatrics | |
| EP2522233A3 (en) | Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid | |
| PH12017502350A1 (en) | Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants | |
| NZ601141A (en) | Nutritional formulas containing synbiotics | |
| MX2010007038A (es) | Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten. | |
| IN2012DN00760A (enExample) | ||
| MY187630A (en) | Pediatric nutritional composition with human milk oligosaccharides, prebiotics and probiotics | |
| MY166946A (en) | Methods of using human milk oligosaccharides for improving airway respiratory health | |
| EP4306165A3 (en) | Compositions, uses and methods for treatment of metabolic disorders and diseases | |
| WO2011044516A3 (en) | Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease | |
| NZ771554A (en) | Nutritional composition for promoting intestinal health | |
| MY175195A (en) | Nutritional compositions | |
| Difonzo et al. | Inulin from globe artichoke roots: A promising ingredient for the production of functional fresh pasta | |
| de Souza Aquino et al. | Models to evaluate the prebiotic potential of foods | |
| Bavaro et al. | Potential prebiotic effect of inulin-enriched pasta after in vitro gastrointestinal digestion and simulated gut fermentation | |
| Pascoal et al. | Impact of onion (Allium cepa L) fructans fermentation on the cecum of rats and the use of in vitro biomarkers to assess in vivo effects | |
| Paliwal et al. | Potential health benefits of onion (Allium cepa), Garlic (Allium sativum) and turmeric (Curcuma) as prebiotics | |
| PH12022551123A1 (en) | Nutritional compositions for treating a clostridium difficile infection | |
| Paliwal et al. | Indian potential health benefits of onion (Allium cepa), garlic (Allium sativum) and turmeric (Curcuma) as prebiotics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2016 BY KATHERINE TEMER Effective date: 20150214 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2017 BY CPA GLOBAL Effective date: 20160129 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2018 BY CPA GLOBAL Effective date: 20170127 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2019 BY CPA GLOBAL Effective date: 20180125 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2020 BY CPA GLOBAL Effective date: 20190124 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2021 BY CPA GLOBAL Effective date: 20200123 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2022 BY CPA GLOBAL Effective date: 20210121 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2023 BY CPA GLOBAL Effective date: 20220128 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2024 BY CPA GLOBAL Effective date: 20230127 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20240125 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAR 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20250123 |